Short answer · Medically reviewed summary · Last updated: 2026-04-07
Gillespie syndrome is an exceptionally rare genetic condition characterized by a specific eye abnormality known as partial aniridia (the partial absence of the iris), combined with non-progressive ataxia (problems with balance and coordination) and intellectual disability. It is a lifelong condition that typically presents in early childhood, requiring multidisciplinary care to manage its neurological and ophthalmological effects. What are the primary symptoms of Gillespie syndrome? The clinical presentation of Gillespie syndrome is defined by a triad of symptoms, though the severity can vary significantly between individuals.
Gillespie syndrome is an exceptionally rare genetic condition characterized by a specific eye abnormality known as partial aniridia (the partial absence of the iris), combined with non-progressive ataxia (problems with balance and coordination) and intellectual disability. It is a lifelong condition that typically presents in early childhood, requiring multidisciplinary care to manage its neurological and ophthalmological effects.
The clinical presentation of Gillespie syndrome is defined by a triad of symptoms, though the severity can vary significantly between individuals. The hallmark feature is bilateral partial aniridia, which creates a distinct "scalloped" appearance of the pupils; this often leads to light sensitivity (photophobia) and nystagmus (involuntary eye movement). In addition to these eye findings, individuals with Gillespie syndrome typically exhibit cerebellar ataxia, which manifests as delayed motor milestones, balance difficulties, and an unsteady gait. Intellectual disability is also a core feature, ranging from mild to moderate in most documented cases.
Gillespie syndrome is a genetic disorder caused by mutations in the PAX6 gene, which plays a critical role in the development of the eyes, brain, and central nervous system. Unlike other forms of aniridia that may involve the entire iris, the mutations associated with Gillespie syndrome specifically interfere with the development of the iris sphincter muscle. The condition follows an autosomal dominant inheritance pattern, meaning a child only needs to inherit one copy of the mutated gene from an affected parent to develop the syndrome, though many cases arise from *de novo* (spontaneous) mutations where neither parent is affected.
Diagnosis is usually suspected during an ophthalmological examination when a physician identifies the characteristic scalloped pupils. Confirmation is achieved through molecular genetic testing to identify a pathogenic variant in the PAX6 gene. Because Gillespie syndrome is so rare, it is often misdiagnosed as other forms of congenital aniridia. Key differentiating factors include:
Gillespie syndrome is classified as an ultra-rare disease. While exact global prevalence numbers are difficult to ascertain due to under-reporting, the condition is estimated to affect fewer than 1 in 1,000,000 individuals worldwide. Within the DiseaseMaps community, 9 people with Gillespie syndrome have connected to share their experiences, reflecting the very small global patient population. Because it is so rare, there is no gender or geographic predilection; it occurs with equal frequency across all populations.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.